Product Theaters are a forum for Annual Meeting Exhibitors to interact with attendees in an intimate theater setting. Product Theaters provide an opportunity to gather and discuss issues on patient education and therapeutic areas, demonstrate new and existing products and provide up-to-date research findings.

Friday, April 27th

Lunch | 12:15 – 1:00pm, Hilton Austin, Salon F
Innovations in the Treatment of BV: A Complete Course of Therapy in a Single Dose
Supported by: Lupin Pharmaceuticals, Inc.
Explore the scope, impact, and unmet needs of bacterial vaginosis (BV). Michael L. Krychman, MD, will examine current theories of BV pathogenesis along with diagnostic criteria and methods; as well as review current and soon to be available US treatments. Dr. Krychman and content are sponsored by Lupin Pharmaceuticals, Inc.

Lunch | 12:15 – 1:00 pm, Hilton Austin, Salon G
The Fibroid Effect: The Impactful Consequences of Uterine Fibroids
Supported by: Allergan
How are uterine fibroids impacting your patients? Learn more by attending Allergan’s Disease State Theater on “The Fibroid Effect: The Impactful Consequences of Uterine Fibroids”.
Speaker: Jessica Shepherd, MD, MBA, OB/GYN and Women’s Health Expert, Minimally Invasive Gynecology, Baylor University Medical Center- Dallas, TX.

Evening Reception | 5:15 – 6:00 pm, Hilton Austin, Salon F
Libido Myths: Understanding Hypoactive Sexual Desire Disorder (HSDD)
Supported by: AMAG Pharmaceuticals
This product theater will give attendees the opportunity to: (1) understand the neurobiological and biopsychosocial underpinnings of HSDD; (2) understand the sexual response cycle models; (3) understand the biopsychosocial construct of HSDD in women; and (4) receive insights into the Patient Reported Outcomes (PROs) used to assess sexual function in women.

Evening Reception | 5:15 – 6:00 pm, Hilton Austin, Salon G
Cumulative Impact of Endometriosis Related Pain: A Call to Action
Supported by: AbbVie
Patients with endometriosis-associated pain, including dysmenorrhea, nonmenstrual pelvic pain, and dyspareunia, present challenges for even the most experienced practitioner. Pain may be refractory or recur after treatment. Moreover, patients may suffer from psychosocial issues that further complicate disease recognition and decision-making. Join us to review management strategies, including a discussion about the role of multidisciplinary care, in caring for patients with endometriosis.

Saturday, April 28th

Breakfast | 7:00 – 7:45 am, Hilton Austin, Salon F
Postpartum Depression: Risk Factors, Screening, and Approaches to Clinical Care
Supported by: Sage Therapeutics
Learn more about PPD with a focus on screening and the valuable role obstetricians can play in screening for and treating PPD. This interactive program will cover: current definitions of PPD, screening recommendations, screening tools for PPD, anxiety as a component of PPD, risk factors for PPD, and current treatment options.

Evening Reception | 5:15 – 6:00 pm, Hilton Austin, Salon F
In Office Procedures: Up Your Game
Supported by: Hologic
Navigating the evolving healthcare landscape can be challenging and nuanced. Office-based procedures are patient-centered, efficient, and can be economically beneficial for your practice. Join us to learn about cutting edge technologies that treat common GYN issues such as abnormal uterine bleeding and painful symptoms of menopause, in the convenience of your office. – Neeraj Kohli, MD, MBA

Evening Reception | 5:15 – 6:00 pm, Hilton Austin, Salon G
An Innovative Treatment for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy (VVA), Due to Menopause
Supported by: AMAG Pharmaceuticals, Inc.
Round out your experience by attending this live seminar. We will review dyspareunia due to menopause and take a closer look at an innovative treatment for moderate to severe dyspareunia, a symptom of VVA, due to menopause.

Sunday, April 29th

Breakfast | 7:00 – 7:45 am, Hilton Austin, Salon F
Importance of Health Care Provider–Patient Dialogue in Contraceptive Selection
Supported by: Merck
Objectives: Discuss unintended pregnancy and importance of contraceptive dialogue for selection of the most appropriate method; Review characteristics of, and clinical data for, a nondaily contraceptive; Discuss how to efficiently and effectively implement a nondaily contraceptive in clinical practice.

Breakfast | 7:00 – 7:45 am, Hilton Austin, Salon G
Managing the Dense Breast Patient
Supported by: Hologic
Women with dense breast tissue are at higher risk for developing breast cancer. Breast density reporting, imaging and optimizing healthcare relationships for this population are discussed.

  • ACR BI-RADS breast density categories
  • Dense Breast Reporting Letter
  • All breast imaging technologies are not the same

Lunch | 12:15 – 1:00 pm, Hilton Austin, Salon F
Right Patient, Right Timing, Right Way of Induction
Supported by: Ferring Pharmaceuticals
An interactive, audience-involved debate discussing how to leverage the recent data on labor induction with guidelines for reduction in cesarean section to improve outcomes.

Lunch | 12:15 – 1:00 pm, Hilton Austin, Salon G
To App or not to App?
Supported by: Clearblue
Free fertility apps are widely available – claiming to be able to predict ovulation on cycle length alone. How accurate are these ovulation prediction Apps that your patients could be using?

Lunch | 12:15 – 1:00 pm, Hilton Austin, Salon H
Addressing Patient Confusion Around Genetic Testing
Supported by: Counsyl
Genetic testing is quickly becoming the standard of care in the prenatal or annual exam setting. Dr. Rebecca Booth (OBGYN) and Dr. Katherine Diase (OBGYN) will address practical approaches to discussing genetic testing options with patients.

Evening Reception | 5:15 – 6:00 pm Hilton Austin, Salon F
Delivering Endometriosis Care
Supported by: AbbVie
A fresh look at the management of endometriosis pain

Evening Reception | 5:15 – 6:00 pm Hilton Austin, Salon G
Breast density: Why it matters and what to do.
Supported by: GE Healthcare
Breast density obscures cancers on a mammogram and recent research indicates it is the leading common risk factor for development of breast cancer. The topic is a frequent fixture on social media, news and medical literature. Learn about clinical and radiological challenges, current research, tools and strategies for managing patients with dense breasts.


Interested in learning how to sponsor a Product Theater at the 2018 Annual Clinical & Scientific Meeting? For questions or information on available time slots, please contact Jenny McIver-Brocious, View the 2018 Product Theater information and application.

© 2018 American College of Obstetricians and Gynecologists. All Rights Reserved. Use of this Web site constitutes acceptance of our Terms of Use.